Acute community acquired Aspergillus pneumonia in a presumed immunocompetent host

Varun Sridhar1, Natarajan Rajagopalan, C Shivaprasad

  • 1Internal Medicine Department, Narayana Hrudayalaya Hospital, Bangalore, Karnataka, India.

BMJ Case Reports
|May 19, 2012
PubMed

Insights

Acute Aspergillus pneumonia, though often fatal in healthy individuals, can be survived. Early diagnosis and voriconazole treatment are key to successful outcomes in these rare community-acquired fungal infections.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Pulmonology

Background:

  • Aspergillus infections typically affect immunocompromised individuals.
  • Invasive Aspergillosis and Aspergillus pneumonia can be severe, even fatal.
  • Acute pneumonia caused by Aspergillus in immunocompetent hosts is rare and often lethal.

Observation:

  • The case involved an immunocompetent host presenting with acute community-acquired Aspergillus pneumonia.
  • Radiographs showed bilateral chest infiltrates, indicative of severe pneumonia.
  • The patient's immunocompetent status made the diagnosis and prognosis challenging.

Findings:

  • Early clinical suspicion was crucial for prompt diagnosis.
  • Microbiological identification via bronchoalveolar lavage confirmed Aspergillus infection.
  • Initiation of voriconazole therapy was critical for patient survival.

Implications:

  • This case highlights the possibility of survival in immunocompetent patients with severe Aspergillus pneumonia.
  • Emphasizes the importance of early recognition and aggressive antifungal treatment.
  • Suggests voriconazole as a potentially life-saving therapy in such critical cases.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Fungal Phylum Ascomycota01:28

Fungal Phylum Ascomycota

Phylum Ascomycota, a major division within the subkingdom Dikarya, comprises a diverse range of fungal species, including both unicellular yeasts and filamentous molds such as Aspergillus and Penicillium. These fungi thrive in a variety of habitats, from aquatic ecosystems to terrestrial environments, playing crucial ecological and economic roles.Morphology and ReproductionThe defining characteristic of Ascomycetes, commonly referred to as sac fungi, is the ascus—a sac-like structure that...
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps: